Latest NxStage Medical Inc. Stories
LAWRENCE, Mass., May 14, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that former NxStage® System One(TM) patient Nikolas Gieske of Mequon, Wisconsin, received a kidney transplant following four successful years of more frequent home hemodialysis with the System One. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) The freedom to do his dialysis treatments on his own schedule...
LAWRENCE, Mass., May 11, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq:NXTM), a leading manufacturer of innovative dialysis products, today commented on findings of the Chronic Disease Research Group (CDRG) study showing that patients receiving daily, or more frequent, home hemodialysis with the NxStage System One(TM) are more likely to receive a kidney transplant when compared with conventional thrice-weekly dialysis, particularly in patients not on the transplant waitlist...
LAWRENCE, Mass., May 8, 2012 /PRNewswire/ -- Highlights: Total Revenue Increases 13% to $57.0 million Home Revenue Increases 13% to $29.6 million Company Converts Outstanding Debt to Equity with Strategic Partner, Asahi Kasei Medical Co., Ltd. and Announces System One Collaboration in Japan NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today reported financial results for the first quarter ended March 31, 2012, with total revenue...
LAWRENCE, Mass., April 13, 2012 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the first quarter ended March 31, 2012 on Tuesday, May 8, 2012 before the opening of the financial markets. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO) NxStage will also host a conference call at 9:00 a.m. Eastern Time on Tuesday, May 8, 2012 to discuss its first...
LAWRENCE, Mass., Feb. 29, 2012 /PRNewswire/ -- Highlights: Full-Year Revenue Increases to $217.3 Million, 21% Annual GrowthFull-Year Home Revenue Increases to $108.5 Million, 27% Annual GrowthFull- Year Gross Margin Improves to 36%, up from 32% for 2010Q4'11 Revenue Increases to a Record $57.0 Million, up 15% from Q4'10Company Applauds Favorable Coverage Decision Supporting More Frequent Home Hemodialysis by UnitedHealthcareNxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of...
LAWRENCE, Mass. and SAN ANTONIO, Feb. 24, 2012 /PRNewswire/ -- ADC 2012 Booth B -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that it is participating in several industry-focused educational presentations on more frequent home hemodialysis with the NxStage System One(TM) at the Annual Dialysis Conference (ADC) 2012. NxStage will also host a special reception event, featuring celebrity kidney transplant patient and...
LAWRENCE, Mass., Jan. 20, 2012 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the fourth quarter and full year ended December 31, 2011 on Wednesday, February 29, 2012 before the opening of the financial markets. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) NxStage will also host a conference call at 9:00 a.m. Eastern Time on Wednesday,...
LAWRENCE, Mass., Jan. 9, 2012 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that its Medisystems in-center business and B. Braun Medical Inc. have agreed to extend their supply agreement under which Medisystems will supply B. Braun with its Streamline(®) blood tubing sets for use on the B. Braun Dialog(®) and Dialog(+® )hemodialysis systems, Medisystems MasterGuard(®) and Buttonhole(®) needles, and...
LAWRENCE, Mass., Jan. 4, 2012 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer and Robert Brown, Chief Financial Officer will present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on January 10th, at 4 p.m. PST. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) A webcast of the event will be made available at...
LAWRENCE, Mass., Nov. 22, 2011 /PRNewswire/ -- Taking control of your dialysis and finding the information you need about home hemodialysis with the NxStage(®) System One((TM)) just got easier for end stage renal disease (ESRD) patients with the launch of the NxStage Find a Doctor directory. The on-line directory created by NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, makes it easier for patients to identify a nearby nephrologist...
